The FDA has approved SucroMate Equine, an injectable drug that increases the likelihood of conception for both naturally bred and artificially inseminated horses.
Manufactured by Thorn BioScience, a subsidiary of CreoSalus, Inc., SucroMate Equine regulates ovulation in mares. It is one of only eight new FDA approved animal health drugs in 2010.
SucroMate Equine delivers a [no-glossary] stable, sterile and consistent dosage of deslorelin for mare ovulation and provides veterinarians and horse owners confidence in breeding their mares.
CreoSalus also announced a national distribution agreement for SucroMate Equine with Bioniche Life Sciences. Jim Phillips, President of Bioniche Animal Health reported,"SucroMate Equine is a natural fit with our portfolio of reproductive drugs....With up to 300,000 mares bred anually, we believe the market prospects for this new product are strong."
SucroMate Equine will be available for veterinarians through distributors at the start of the 2011 breeding season in February.
About the author
As an animal lover since childhood, Flossie was delighted when Mark, the CEO and developer of EquiMed asked her to join his team of contributors.
She enrolled in My Horse University at Michigan State and completed a number of courses in everything related to horse health, nutrition, diseases and conditions, medications, hoof and dental care, barn safety, and first aid.
Staying up-to-date on the latest developments in horse care and equine health is now a habit, and she enjoys sharing a wealth of information with horse owners everywhere..